Draper Asset Management, LLC Crispr Therapeutics Ag Transaction History
Draper Asset Management, LLC
- $139 Million
- Q2 2024
A detailed history of Draper Asset Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Draper Asset Management, LLC holds 7,892 shares of CRSP stock, worth $399,256. This represents 0.31% of its overall portfolio holdings.
Number of Shares
7,892
Previous 7,912
0.25%
Holding current value
$399,256
Previous $539,000
20.96%
% of portfolio
0.31%
Previous 0.45%
Shares
15 transactions
Others Institutions Holding CRSP
# of Institutions
505Shares Held
57.3MCall Options Held
1.74MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$398 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$379 Million3.35% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$159 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$150 Million0.1% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$141 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.95B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....